Performance evaluation of an Inveon PET preclinical scanner.
about
Evaluation of 18F-nifene binding to α4β2 nicotinic receptors in the rat brain using microPET imagingQuantitative assessment of brown adipose tissue metabolic activity and volume using 18F-FDG PET/CT and β3-adrenergic receptor activationIn vivo molecular imaging of experimental joint inflammation by combined (18)F-FDG positron emission tomography and computed tomography.The use of the NIS reporter gene for optimizing oncolytic virotherapyWhole animal imaging.Nicotinic acetylcholine receptors in rat forebrain that bind ¹⁸F-nifene: relating PET imaging, autoradiography, and behavior.Comparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humansHigh-frequency repetitive transcranial magnetic stimulation for treating moderate traumatic brain injury in rats: A pilot study.Development of novel approach to diagnostic imaging of lung cancer with 18F-Nifene PET/CT using A/J mice treated with NNK.Evaluation of serotonin 5-HT(1A) receptors in rodent models using [¹⁸F]mefway PET.Development of a PET scanner for simultaneously imaging small animals with MRI and PET.Nicotinic α4β2 receptor imaging agents. Part IV. Synthesis and biological evaluation of 3-(2-(S)-3,4-dehydropyrrolinyl methoxy)-5-(3'-¹⁸F-fluoropropyl)pyridine (¹⁸F-Nifrolene) using PET.PET imaging of acetylcholinesterase inhibitor-induced effects on α4β2 nicotinic acetylcholine receptor bindingHigh-throughput multiple-mouse imaging with micro-PET/CT for whole-skeleton assessment.64Cu-labeled somatostatin analogues conjugated with cross-bridged phosphonate-based chelators via strain-promoted click chemistry for PET imaging: in silico through in vivo studiesConstruction and evaluation of quantitative small-animal PET probabilistic atlases for [¹⁸F]FDG and [¹⁸F]FECT functional mapping of the mouse brainStriatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹⁸F]fallypride and [¹⁸F]desmethoxyfallyprideA multi-atlas based method for automated anatomical rat brain MRI segmentation and extraction of PET activityDopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.The effects of lobeline on α4β2* nicotinic acetylcholine receptor binding and uptake of [(18)F]nifene in rats.Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease.An alternative approach to histopathological validation of PET imaging for radiation therapy image-guidance: a proof of conceptOn the assessment of spatial resolution of PET systems with iterative image reconstruction.Synthesis and biological evaluation of 18F-Norfallypride in the rodent brain using PET imaging.Positron emission tomography assessment of 8-OH-DPAT-mediated changes in an index of cerebral glucose metabolism in female marmosets.Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity.Comparison of Imaging Characteristics of (124)I PET for Determination of Optimal Energy Window on the Siemens Inveon PET.Development of a novel depth of interaction PET detector using highly multiplexed G-APD cross-strip encoding.In-depth Characterization of a TCR-specific Tracer for Sensitive Detection of Tumor-directed Transgenic T Cells by Immuno-PETUltrahigh-resolution Cerenkov-light imaging system for positron radionuclides: potential applications and limitations.Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride18 F-Fluoride positron emission tomography/computed tomography for noninvasive in vivo quantification of pathophysiological bone metabolism in experimental murine arthritis.Synthesis and evaluation of (S)-[(18)F]fesetron in the rat brain as a potential PET imaging agent for serotonin 5-HT3 receptorsEvaluation of [11C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT.Feasibility of sequential PET/MRI using a state-of-the-art small animal PET and a 1 T benchtop MRI.PET radiotracer development for imaging high-affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine-18 labeled aminotetralins in rodents.Transplantation of Flk-1+ human bone marrow-derived mesenchymal stem cells promotes angiogenesis and neurogenesis after cerebral ischemia in rats.Human brain imaging of nicotinic acetylcholine α4β2* receptors using [18 F]Nifene: Selectivity, functional activity, toxicity, aging effects, gender effects, and extrathalamic pathways.Environmental enrichment enhances synaptic plasticity by internalization of striatal dopamine transporters.An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model.
P2860
Q21195727-C3F71D4E-243D-4E72-8CCA-783684ACE521Q21195728-74327A6D-17C5-4C7C-B17A-C53FFDF443BAQ22000844-FEF16863-C6F8-46EC-A26B-0F769B8197D6Q28083534-06BB5E03-29F5-4E10-9D3F-350FF920C99BQ30411800-75BF31ED-E555-4F76-8C31-EE787BB1F1A2Q30455122-24429EEE-84CF-4B8D-8CF2-AB9C93CB463FQ30724808-EA699F7A-EB35-49B4-A02D-33505EA103F9Q33723747-FDD3677B-8D17-4DDE-8B4C-58D6AE154ED9Q33724057-BE3EE9FA-E3EC-44C7-9D66-418F0655990CQ34036060-DF89656B-86E9-4D8C-AF52-7B50035E5CA3Q34262681-72860E25-9125-49ED-8095-EFBB0609879EQ34310935-30C7DB17-3AB0-411F-9B1F-5FC0116A73D2Q34361691-EE94435F-B7BC-45B0-AF3D-770169F6AC2FQ34616618-0C2DB260-3C22-459A-8409-D933AEE505EBQ34665668-B1E25EFD-F7AD-4AD4-8E4B-AA5BEBC0C7E1Q34769782-B09B0C03-8210-40EC-A40D-69324AFD188CQ35024059-5788CD43-03E8-4F84-88EB-DC6B929433B3Q35349838-522EE4D6-0F3F-4BCC-B92A-D78F50B9420FQ36219773-8E9E192E-A00E-4752-81D8-2184E609D6A7Q36816175-D14DFFD1-870C-4401-BEC9-3C5455264FE5Q36884880-19BB7648-F026-4C87-A778-39CAAEFFD3FAQ36885338-B323094B-A333-417A-A7D8-99C28A55E1B1Q36961177-74DFDA8A-A103-4D84-9003-9ABE9D20FD31Q37117235-6778B64A-746C-4F20-9275-2978C5E98894Q37149273-BCC10B51-5374-4D7C-8FAE-4EE6AA2EC850Q37256662-E0483B47-E739-4AC1-8528-C0031B96FDCBQ39862429-00372609-3C79-4F8E-9137-EF71243BAF43Q40212006-D6FEFC9C-D115-4DE9-9621-E19F9D62321CQ41114267-C099F04A-2DE8-4D50-9DB2-D2C862FB5273Q41664535-40B0CF8E-AFF8-48C9-9740-198A1ED45CC1Q41790133-4E43CD83-B924-42C0-AC72-6B6EBA93B88CQ41811951-7A2C1E64-FCE5-4D78-A09E-103613942C26Q42205380-65799E19-C336-4A44-8361-765F68DECFD5Q42315307-9E0E6342-8082-4FD9-844F-E72D9911661CQ45719364-604DD960-F401-45F1-8DF8-D499502661D6Q45995692-98653295-C979-439C-9BA8-FA11D3D3AD64Q46045666-A1FE2A8A-0B52-4D6C-97F4-0F2B98C341F8Q46311520-B38D1F80-CE2D-4CA9-8D5A-510C885B4834Q47220512-45D0F070-CEB5-485A-BBC9-6349A530A895Q47553769-BA7E372C-2D7D-4E8F-B823-A781647EE569
P2860
Performance evaluation of an Inveon PET preclinical scanner.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Performance evaluation of an Inveon PET preclinical scanner.
@ast
Performance evaluation of an Inveon PET preclinical scanner.
@en
type
label
Performance evaluation of an Inveon PET preclinical scanner.
@ast
Performance evaluation of an Inveon PET preclinical scanner.
@en
prefLabel
Performance evaluation of an Inveon PET preclinical scanner.
@ast
Performance evaluation of an Inveon PET preclinical scanner.
@en
P2860
P356
P1476
Performance evaluation of an Inveon PET preclinical scanner
@en
P2093
Cristian C Constantinescu
P2860
P304
P356
10.1088/0031-9155/54/9/020
P577
2009-04-21T00:00:00Z